Baylor College of Medicine well as the unexpanded , and the Houston, Texas 77030 absence of ataxin-1 in the mouse does not cause ataxia (Matilla et al., 1998) , work has focused on identifying a pathogenic gain-in function exerted by the expanded Summary protein. One approach has been to identify cellular components that interact with the disease protein in normal Transgenic mice carrying the spinocerebellar ataxia and pathological circumstances (Koshy et al., 1996 ; Coltype 1 (SCA1) gene, a polyglutamine neurodegeneraomer et al. Wanker et al., 1997) . tive disorder, develop ataxia with ataxin-1 localized to
In yeast two-hybrid experiments, the widely expressed aggregates within cerebellar Purkinje cells nuclei. To glycolytic enzyme GAPDH and the Purkinje-enriched examine the importance of nuclear localization and leucine-rich acidic nuclear protein (LANP) have been aggregation in pathogenesis, mice expressing ataxinshown to bind to ataxin-1. Considering that Purkinje 1[82] with a mutated NLS were established. These cell pathology is a prominent feature of SCA1, LANP is mice did not develop disease, demonstrating that nuparticularly intriguing as a possible pathogenic cofactor, clear localization is critical for pathogenesis. In a secespecially since the interaction is enhanced with longer ond series of transgenic mice, ataxin-1[77] containing polyglutamine tracts. Furthermore, the LANP protein has a deletion within the self-association region was exbeen shown to be included in ataxin-1 aggregates in pressed within Purkinje cells nuclei. These mice develtransfected cells . Another approach has been to investigate the propenoped ataxia and Purkinje cell pathology similar to the sity of these proteins to self-associate and, in particular, original SCA1 mice. However, no evidence of nuclear to form insoluble aggregates (Ross, 1997) . This pathoataxin-1 aggregates was found. Thus, although nugenic mechanism was first proposed (Perutz et al., 1994 ) clear localization of ataxin-1 is necessary, nuclear agbefore any such aggregates had been observed in vivo. gregation of ataxin-1 is not required to initiate pathoSubsequently, aggregates containing the disease progenesis in transgenic mice.
tein have been found in HD and SCA1 transgenic mouse neurons Skinner et al., 1997) . Similar Introduction nuclear aggregates were also discovered in a SCA1 brain (Skinner et al., 1997) , as well as HD (Davies et al., A number of inherited neurodegenerative diseases in-1997; , SCA3 (Paulson et al., 1997) , volve an expanded polyglutamine repeat within the and DRPLA brains (Becher et al., 1997) . In some discoding sequence of the disease gene. This group of eases, such as SCA1, the aggregates are entirely nudisorders now includes Huntington disease (HD) (Hunclear, while in others, such as HD, they may additionally tington's Disease Collaborative Research Group, 1993) , appear in neurites. spinobulbar muscular atrophy (SBMA) (La Spada, 1991) , It has been suggested that the neuronal aggregates dentatorubral pallidoluysian atrophy (DRPLA) (Koide et are the common mechanism of neuropathology for inal., 1994; Nagafuchi et al., 1994) , and the spinocerebellar herited polyglutamine disorders (Ross, 1997 ; Davies et ataxias type 1, 2, 3, 6, and 7 (Orr et al., 1993; Kawaguchi al., 1998) . However, the location of the aggregates does et Imbert et al., 1996; Pulst et al., 1996;  Sanpei not necessarily correlate with the localization of the soluet al., 1996; David et al., 1997; Koob et al., 1998) . In the ble protein. In Purkinje cells, ataxin-1 is both nuclear disease allele the repeat tract is unstable, expanding and cytoplasmic , while in the various neuronal types affected in HD, huntingtin is cytoplasmic (DiFiglia et al., 1995; Gutekunst et al., 1995; 7 To whom correspondence should be addressed (e-mail: harry@ Sharp et al., 1995) . Thus, localization of the diseaselenti.med.umn.edu). 8 These authors contributed equally to this work.
causing protein to the nucleus may be due either to its normal cellular distribution, in the case of ataxin-1, or to events that are a result of an increase in the number of glutamines, in the case of huntingtin. The predominant localization of ataxin-1 to the nucleus of Purkinje cells in SCA1 transgenic mice (Orr and Zoghbi, 1996; Skinner et al., 1997) and the occurrence of nuclear alterations associated with the expression of ataxin-1 with an expanded polyglutamine tract suggest that the primary site of pathogenesis is nuclear. However, ataxin-1 is also found in the cytoplasm, and the appearance of cytoplasmic vacuoles is the first morphological alteration seen in SCA1 transgenic Purkinje cells (Clark et al., 1997) . To determine directly whether the expression of ataxin-1 with an expanded polyglutamine tract in a specific cellular compartment is a prerequisite for pathogenesis in vivo, we created an ataxin-1[82] NLS mutant that contains a single point mutation, ataxin-1
K772T
. We next generated ataxin-1 K772T transgenic mice with the same Purkinje cell-specific regulatory element, Pcp2, as used by Burright et al. (1995) . In a similar fashion, we developed a second series of SCA1 transgenic mice containing a deletion within the self-association region Though NLSs can be quite variable in appearance, many acids 760-816 from ataxin-1 containing the K772T substitution. Subconform to the consensus cluster of arginines and lycellular localization was determined by immunofluorescence using sines found in SV40 T antigen (Boulikas, 1993) . Visual the anti-FLAG antibody M5.
and computer-aided inspection of the ataxin-1 amino acid sequence revealed two possible NLSs of this type, one near the N terminus at lysine 15 and one near the was still apparent in the nucleus. To verify that lysine C terminus at lysine 772. There was no homology to 772 is indeed part of a functional NLS, a PCR-based selected unique transport sequences such as the M9 strategy was used to fuse the C-terminal portion of sequence of hnRNP A1 (Siomi and Dreyfuss, 1995) or ataxin-1 containing the putative NLS (amino acids 760-to nuclear export sequences (Gerace, 1995) . 816) to the cytoplasmic protein chicken muscle pyruvate Both putative NLSs were separately mutated with a kinase (CMPK) (Frangioni and Neel, 1993) . The C-termisingle base pair change replacing the lysines at amino nal ataxin-1/CMPK protein was expressed in the COS-1 acid residues 15 and 772 with threonines, ataxin-1 K15T cells. The result was dramatic; CMPK was totally shifted and ataxin-1 K772T , respectively. This amino acid substitufrom the cytoplasmic to the nuclear compartment, demtion has been shown to disrupt the function of the SV40 T onstrating that the fused portion of ataxin-1 contained antigen NLS (Kalderon et al., 1984a (Kalderon et al., , 1984b . The mutated a strong functional NLS ( Figure 1C ). When the same cDNA clones were inserted into eukaryotic expression portion of the K772T mutant was fused to CMPK, CMPK vectors and expressed in COS-1 cells. Indirect immunoremained completely in the cytoplasm ( Figure 1D ). This fluorescence was performed using either the M5 antidemonstrated that the function of the C-terminal NLS FLAG monoclonal antibody against a FLAG sequence could be completely abolished with the single K772T engineered into the N terminus of ataxin-1 or using the substitution. polyclonal 11750 ataxin-1 antisera directed against a C-terminal peptide . Ataxin-1 localized to the nucleus of transiently transfected COS-1 Ataxin-1 K772T Transgenic Mice Express Ataxin-1 cells. When ataxin-1 K15T was expressed in COS-1 cells, in the Cytoplasm of Purkinje Cells it localized to the nucleus suggesting that the N-terminal Mutant ataxin-1 cDNA with 82 CAG repeats was inserted putative NLS is not necessary for nuclear localization into the Pcp2 Purkinje cell-specific promoter plasmid ( Figure 1A) . In contrast to K15T, the K772T mutation pCEVII, used to establish the earlier SCA1 transgenic did cause a shift in distribution of ataxin-1[82] to the mice (Burright et al., 1995) . After implantation of injected embryos, 94 pups were born, of which 9 were identified cytoplasm ( Figure 1B) . However, substantial staining as positive for the transgene. Seven founders bred sucdistinguishable from that of nontransgenic mice, with a slight indication of a diffuse distribution of ataxin-1 in cessfully. Southern blot analysis of tail DNA from the N1 generation revealed that copy number ranged from the cytoplasm and no detectable ataxin-1 in the nucleus ( Figure 1F ). 1 to 30 among lines. To determine approximate levels of protein expression, semiquantitative immunofluoresTo further examine the level of transgene expression in the ataxin-1 K772T transgenic lines, Northern blotting cence was used. Results showed that the level of ataxin-1 expression in the Purkinje cells of the ataxinwas performed. Using total cerebellar RNA from 4-weekold mice, a single band of approximately 3.3 kb (3.1 kb 1 K772T lines was roughly comparable to that of the SCA1 transgenic line B05. In particular, two ataxin-1 K772T transin A02 RNA) was detected in transgenic mice ( Figure  3A ). The density of the bands for 772-17/ϩ, B05/ϩ, and genic lines, 772-2 and 772-17, accumulated levels of transgene product somewhat greater than those of the A02/A02 transgene RNA was roughly equal. This is consistent with previous characterization of the A02 and B05 line.
The immunofluorescence analysis also revealed the B05 transgenic lines, where B05/ϩ was found to express approximately twice the transgenic RNA of A02/ϩ (Bursubcellular distribution of ataxin-1 K772T in Purkinje cells (Figure 2 ). Despite the fact that in COS-1 cells the muright et al., 1995) . Since the onset of disease in SCA1 mice depends not only on peak RNA levels, but also on tated protein still entered the nucleus in substantial amounts, in Purkinje cells ataxin-1 K772T was observed to the developmental onset of expression (Burright et al., 1995) , Northern blot analysis was further extended to remain mostly cytoplasmic with no indication of aggregates (Figures 2A-2C ). Thus, in contrast to COS-1 cells, 8-, 10-, and 14-day-old 772-2 mice ( Figure 3B ). Ataxin-1 K772T transgene RNA was clearly detectable at 8 days, in Purkinje cells the NLS at amino acids 771-774 is the predominant determinant of nuclear localization for which is comparable if not even earlier than previously reported for the onset of SCA1 RNA in the B05 transataxin-1. Using the N-terminal 11NQ antibody (Skinner et al., 1997) , the C-terminal 11750 antibody, and the genic line. Ataxin-1 expression was also characterized by Westexpanded polyglutamine antibody 1F8 (White et al., 1997) , a similar distribution of ataxin-1 K772T within Purern blotting of crude extracts from cerebella of 4-to 5-week-old transgenic mice. Using the 11750 antibody kinje cells was observed. The majority of ataxin-1 K772T was in the cytoplasm. In contrast, B05 transgenic Pur-( Figure 3C ), full-length ataxin-1 K772T was readily detectable in cerebellar extracts prepared from both K772T kinje cells showed strong nuclear staining for ataxin-1. In Purkinje cells of B05 transgenic mice, both ataxin-1 transgenic lines. In contrast, full-length ataxin-1 was barely detectable in cerebellar extracts prepared from antibodies 11750 and 11NQ showed a strong nuclear localization of ataxin-1 but with an interesting differ-B05 transgenic mice. The inability to detect by Western blot the ataxin-1 transgene product in B05 cerebellar ence between the two antibodies. With antibody 11750, ataxin-1 was found diffusely throughout the nucleus as extracts is consistent with earlier observations (Burright et al., 1995) . While the explanation for this remains unwell as in aggregates ( Figure 2D ). With antibody 11NQ, ataxin-1 was localized predominantly to nuclear aggreclear, it strongly suggests that ataxin-1 containing an expanded number of polyglutamines becomes insoluble gates and little diffuse localization was seen ( Figure 2E ). Using the 1F8 antibody directed against expanded polywhen expressed in Purkinje cell nuclei. In addition to the full-length ataxin-1 bands, transgene-specific lower glutamine tracts, staining of B05 Purkinje cells was barely readily detectable in cerebellar extracts prepared from A02 mice and both ataxin-1 K772T transgenic lines. As with the Western blot using the 11750 antibody, 11NQ revealed a relatively faint band corresponding to fulllength transgenic ataxin-1 in an extract from a B05 mouse. In contrast to 11750, the transgene-specific lower molecular weight bands were not detected by 11NQ. Finally, when the blots were probed with the 1F8 antibody (data not shown), the results were identical to those with 11NQ, except that transgenic ataxin-1 [30] and endogenous murine ataxin-1 were not detected. In summary, the Western blot data show that full-length cytoplasmic ataxin- after birth (Burright et al., 1995; Clark et al., 1997) . Both transgenic mice between 12 and 20 weeks of age. Mice heterozygote B05 transgenic mice (Burright et al., 1995) ; and homofrom the ataxin-1 K772T 772-2 line were also assessed on zygote SCA1 ataxin-1[30] A02 transgenic mice (Burright et al., 1995) .
the Rotarod at 36 weeks. Although the sample size was small (n ϭ 2), it was clear that while B05 mice had molecular weight bands were also visible in protein exdecreased to a very minimal performance level, 772-2 tracts from each of the SCA1 transgenic lines. However, mice had not and performed as well as age-matched their size and pattern did not vary with glutamine number control mice. By 36 weeks of age, B05 mice are observed or cellular localization of ataxin-1. Thus, we concluded by cage behavior to be moderately to severely ataxic, that these presumably proteolytic fragments of transwith wide, shuffling gait, and frequent loss of balance genic ataxin-1 are not related to the ability of the while walking or attempting to stand against the wall of transgene product to induce disease in mice and most the cage (Burright et al., 1995; Clark et al., 1997) . In likely are the result of overexpressing human ataxin-1 contrast, 772-2 ataxin-1 K772T mice failed to display any in murine Purkinje cells. Nevertheless, they remain an signs of ataxia to at least 1 year of age. Thus, we conimportant consideration in the interpretation of immunocluded that ataxin-1 K772T transgenic mice do not develop fluorescence data.
the progressive cerebellar dysfunction characteristic of Western blots were also probed with the 11NQ antithe B05 SCA1 transgenic mice, despite expressing comparable amounts of ataxin-1 in their Purkinje cells. body ( Figure 3D ). Full-length transgenic ataxin-1 was hybrid analysis demonstrated that ataxin-1 with 77 glutamines, ataxin-1[77]⌬, containing this deletion were no transgenic mice were stained for calbindin, ataxin-1, and ubiquitin to determine if any of the cellular changes longer self-associated yet still interacted with LANP (data not shown). observed in B05 SCA1 mice (Burright et al., 1995; Clark et al., 1997) COS cells transfected with either type of ataxin-1⌬ were the molecular layer, and no obvious ataxin-1-positive nuclear or cytoplasmic inclusions ( Figure 5B ). Cytoimmunoreactive with all three antibodies, 11750, 11NQ, and 1F8, and ataxin-1⌬ was found to be extractable with plasmic vacuoles were occasionally (approximately 5%) noted, but far less frequently than in B05 cerebella. Purthe nuclear matrix ( Figure 6C ), as had been seen for ataxin-1[82] (Skinner et al., 1997) . However, neither type kinje cells in B05 mice show vacuolation at 3 weeks of age (Clark et al., 1997) , and by 12 weeks of age vacuolaof ataxin-1⌬ molecule formed nuclear aggregates or altered the nuclear distribution of PML, features seen in tion is frequent, loss of dendritic arborization is apparent and accompanied by gliosis and thinning of the molecu-COS cells transfected with intact ataxin-1 (Skinner et al., 1997) . Western blot analysis indicated that each lar layer, and many cell bodies are displaced from the Purkinje cell layer (Clark et al., 1997) . At 40 weeks of ataxin-1⌬ protein was expressed at a level similar to that seen in COS cells transfected with ataxin-1[82] (data age, 772-2 cerebellar histology was still very similar in appearance to that of nontransgenic mice, with no apnot shown). These results indicate that the 122-amino acid sequence deleted in the ataxin-1⌬ constructs may parent progression of the vacuolation ( Figure 5C ). In contrast, many Purkinje cells in 40-week-old B05 mice have a role in the ability of ataxin-1 to form nuclear aggregates. have died, and surviving cells show a radical loss of dendritic arborization (Clark et al., 1997; Figure 5D ).
Although . To examine whether this segment has a role in ataxin-1 function, a termined at 3, 5, 8, and 12 weeks of age using the ataxin-1 antiseras 11750 and 11NQ. At all time points 122-amino acid deletion was introduced into ataxin-1 persed throughout the nucleus and were not preferentially localized to any nuclear structures. Immunogold mice did not form detectable nuclear aggregates (Figures 8A and 8B ). Immunohistochemical analysis using particles were found within the electron-lucent but not within the electron-dense portions of nucleoli, consisan antibody to ubiquitin also failed to reveal any indication of ubiquitinated nuclear aggregates of ataxin-1[77]⌬ tent with free distribution throughout the nucleoplasm. No fibrillary or filamentous elements suggestive of ag-( Figure 8C ).
To examine the subcellular localization of ataxin-1⌬ gregated protein were visualized in either the immunogold material or the unlabeled material with more at the ultrastructural level, one ataxin-1[77]⌬3 and one nontransgenic control mouse at 12 weeks of age were optimal ultrastructural preservation (not shown). Small clusters of particles were seen, however, that might sugused for preembedding immunogold electron microscopy. As expected from the light microscopic immunogest submicroscopic protein aggregation but could also be a result of the silver intensification procedure. Cytocytochemistry, a subset of Purkinje cells from an ataxin-1[77]⌬3 animal were labeled with immunogold particles plasmic immunogold particles were dispersed through the perikarya and were only rarely in direct contact with using antibody 11750. Nuclei of labeled Purkinje cells contained a very high density of immunogold particles, organelles or identifiable cytoskeletal elements. They were frequently found, however, to be near cisternea of to the primary antibody and in sections from the nontransgenic control, indicating a very low level of backrough endoplasmic reticulum and other areas rich in free ribosomes. Other Purkinje cells, granule cells, inground immunogold labeling. Thus, the ultrastructural data indicates that even microscopic aggregation does terneurons, and glia that were examined contained only rare immunogold particles in proportion to the observed not underlie the neuropathology. It is still possible that submicroscopic aggregates of ataxin-1 are formed. level of background particles. Immunogold particles were very rare in sections processed without exposure
Ataxin-1[77]⌬ Transgenic Mice Develop Purkinje Cell Pathology and Ataxia
Cerebellar sections from ataxin-1[77]⌬ mice were examined using antibodies to ataxin-1 and the Purkinje cellspecific protein calbindin. The results of this analysis revealed a progressive Purkinje cell pathology very similar to that seen in ataxin-1[82] transgenic mice Skinner et al., 1997) . At 3 weeks of age, cytoplasmic vacuoles were detected that with increasing age became evident in most Purkinje cells ( Figure  9A ). By 8 weeks of age, shrinkage of the molecular layer and loss of Purkinje cells proximal dendrites were detected ( Figure 9B ). At 12 weeks of age, heterotopic Purkinje cell bodies were seen in ataxin-1[77]⌬ mice ( Figure  9B ). In transgenic mice expressing ataxin-1[82], the nucleoli of Purkinje cells frequently have an eccentric nuclear localization ( Figure 9C) . A similar aberrant localization of nucleoli was found in Purkinje cells of ataxin-1[77]⌬ mice ( Figure 9D ). Thus, except for the formation the Rotatod performance of ataxin-1[77]⌬3 was as comtransfected COS cells, we found that an arginine-lysine NLS containing lysine 772 was partially responsible for promised compared to control nontransgenic littermates, as was the performance of B05 ataxin-1[82] mice moving the protein into the nucleus but that another undefined sequence in ataxin-1 also is important for ( Figure 9E ). Thus, despite the absence of detectable nuclear aggregates of ataxin-1, ataxin-1[77]⌬ mice at enabling its transport into that compartment. In contrast to COS cells, Purkinje cells recognize the 12 weeks of age have a pattern of histological and neurological alterations very similar to that seen in B05 C-terminal NLS of ataxin-1 as the major, if not the sole determinant of ataxin-1 transport into the nucleus. Imtransgenic mice expressing ataxin-1 [82] .
munofluorescence analysis of ataxin-1 K772T expression in transgenic mouse Purkinje cells demonstrated that Discussion most of the ataxin-1 is located outside of the nucleus, in the cytoplasm. This altered subcellular distribution of We report here data concerning the subcellular trafficking and nuclear aggregation of ataxin-1 in transgenic ataxin-1 K772T was seen using antibodies directed to the carboxy-terminal region, the amino-terminal region, and mouse models of the polyglutamine-induced disease SCA1 and the pathological consequences of expressing to the expanded polyglutamine tract of ataxin-1 ( Figure  2) . The difference in ataxin-1 K772T distribution in COS cells a protein with an expanded number of glutamines.
and in Purkinje cells further supports the concept that the nucleocytoplasmic trafficking of ataxin-1 is reguNuclear Localization of Ataxin-1 Is Mediated by an Arginine-Lysine NLS lated by cell-specific factors. These may operate via posttranslational modifications of ataxin-1 or through Nucleocytoplasmic transport has become an important aspect of models explaining the pathogenesis of polyprotein interactions that mask or provide surrogate localization sequences or act as compartmental anchors. glutamine diseases (Ross, 1997; Davies et al., 1998) . For SCA1, previous data have shown that ataxin-1 has a complex subcellular distribution involving both the cytoNuclear Localization of Ataxin-1[82] Is Required for Purkinje Cell Pathogenesis in Transgenic Mice plasm and nucleus depending on cell type; in most neurons ataxin-1 is nuclear, but in Purkinje neurons it is One of the hallmarks of polyglutamine disease in humans is a progressive course that includes cell dysfuncalso partly cytoplasmic, and in nonneuronal cells it is often entirely cytoplasmic . In tion, dysmorphism, and death accompanied by specific , 1997) , and that mutant ataxin-1 alters the subcellular localization of the HDJ-2/HSDJ chaperone and 20s neurological alterations, including many morphological changes found in affected neurons of SCA1 patients, proteosome to the nucleus of SCA1 patient neurons and SCA1 transgenic mouse Purkinje cells (Cummings et that is, nuclear aggregate formation, cytoplasmic vacuoles, loss of dendritic branching, dislocation of the cell al., 1998). In light of the importance of nuclear localization of ataxin-1[82] for development of disease, these body into the molecular layer, and overall shrinkage of the cell, all accompanied by worsening ataxia (Burright proteins are strong candidates for key roles in pathogenesis. et Clark et al., 1997; Skinner et al., 1997) . In contrast to the B05 mice, ataxin-1 K772T transgenic mice, Ataxin-1[82] expressed within the cytoplasm of Purkinje cells is not only nonpathogenic, but also nonagin which the expression of an expanded form of ataxin-1 is largely restricted to the cytoplasm, show no obvious gregating. The lack of cytoplasmic ataxin-1 inclusions implies that either this compartment has positive mechPurkinje cell histopathology or altered neurological phenotype.
anisms that can "handle" large amounts of ataxin-1 with an expanded number of glutamines, or else it lacks speConsidering that the ataxin-1 K772T transgenic lines 772-2 and 772-17 express the SCA1 transgene at levels comcific components necessary for aggregate formation. An example of the former possibility is the compartmentparable to B05 SCA1 mice, it is clear that the NLS mutation K772T has a major impact on the pathogenicity of specific deployment of chaperones, which can reduce aggregate formation (Cummings et al., 1998) , while exataxin-1 [82] . The most probable reason for the lack of disease in the ataxin-1 K772T mice is that the majoramples of the latter possibility include LANP or nuclear matrix proteins Skinner et al., 1997) . ity of the protein is unable to enter the nucleus. This supports the concept that the primary effects of ataxin-1 Another important conclusion to be drawn from the lack of an overt phenotype in ataxin-1 K772T mice is that with an expanded glutamine tract occur within the nuclei of affected cells. This is not entirely unexpected, consid-SCA1 pathogenesis occurs via a protein-, rather than an RNA-, mediated mechanism. The ataxin-1 K772T mice ering the recent observations that the ataxin-1-interacting protein LANP is also strongly expressed within express levels of SCA1 mRNA containing an expanded CAG tract comparable to that found in the B05 SCA1 mouse neurons Skinner et al., 1997 ) transgenic mice. Furthermore, unlike many mRNA conand in brains from HD ; DiFiglia et al., taining nonsense mutations, the K772T mRNA proceeds 1997), SCA3 (Paulson et al., 1997) , and DRPLA patients normally to translation. Yet, in contrast to the B05 SCA1 (Becher et al., 1997) as well as SCA1 patients (Skinner mice, the ataxin-1 K772T fail to develop pathology. Thus, et al., 1997) has lead to the proposal that these nuclear expression of an mRNA encoding an expanded polygluaggregates are the pathological basis for polyglutamine tamine tract does not cause disease.
diseases (Ross, 1997; Davies et al., 1998) . Contrary to this proposal is our demonstration that transgenic mice Full-Length Ataxin-1 Is Central to SCA1
expressing an ataxin-1⌬ protein with 77 glutamines, Transgenic Pathogenesis which does not form detectable nuclear inclusions, deProteolysis of the disease protein has been suggested velop a neurological disease very similar to that seen to play an important role in the pathogenesis of HD in transgenic mice expressing ataxin-1 [82] , which does (Mangiarini et al., 1996) , MJD/SCA3 (Ikeda et al., 1996) , form nuclear aggregates. Thus, the formation of nuclear DRPLA, and SBMA (Wellington et al., 1998) . Western aggregates of ataxin-1 is not required for the initiation blot analysis of protein extracts from the SCA1 transof pathogenesis in this transgenic model. It remains a genic mice demonstrates that ataxin-1 is also subject possibility that nuclear aggregates of ataxin-1 have a to proteolysis ( Figure 3C ). However, an identical pattern role in the progression of disease. of proteolysis was seen in each of the SCA1 transgenic
The importance of ataxin-1 localization to the nucleus lines, regardless of glutamine repeat number, subcellufor development of Purkinje cell pathology is dramatilar localization, and ultimate pathogenicity of the transcally illustrated by the ataxin-1 K772T mice. This point is gene product. Thus, the proteolysis of ataxin-1 does not further exemplified by the extensive overlap in nuclear appear to be specifically correlated with the developalterations seen between Purkinje cells of the ataxinment of disease in SCA1 transgenic mice. More likely, 1[82] and ataxin-1[77]⌬ mice. Even in the absence of it is the result of overexpressing a human protein in nuclear aggregates, the toxic gain of function of mutant murine Purkinje cells. Since only the C-terminal-directed ataxin-1 seems to be targeted toward the Purkinje cell 11750 antibody, and not the N-terminal-directed 11NQ nucleus. Using an in vitro cellular model of HD, Saudou antibody, detect proteolytic fragments of ataxin -1, it apet al. (1998 [this issue of Cell] ) also showed the imporpears that the amino-terminal fragments complementance of nuclear localization for pathogenesis. Interesttary to the C-terminal fragments are unstable in Purkinje ingly, these studies further suggested that nuclear agcells. This, and the fact that the N-terminal fragment gregates of a polyglutamine protein are insufficient to does not include the NLS and is, therefore, identical in induce cell death. B05 and ataxin-1 K772T mice, further suggests that the Finally, the most obvious conclusion that may be formation of a toxic polyglutamine-containing segment drawn from the SCA1 transgenic mice reported here is of ataxin-1 is not a component of the pathogenic prothe importance of the protein context of a polyglutamine cess in the SCA1 transgenic mice. tract in the pathogenic process. The transgenic models In nuclei of B05 Purkinje cells, and to a lesser extent of HD (Mangiarini et al., 1996) and MJD/SCA3 (Ikeda et ataxin-1 K772T Purkinje cells, the diffuse reactivity obal., 1996) used only a small portion of the mutant protein. served with 11750 ( Figures 2A and 2D ) is most likely Another recent work involved inserting a polyglutamine due to the proteolytic fragments seen on 11750 Western tract into a foreign protein context, hypoxanthine phosblots. In the case of B05 Purkinje cells, these C-terminal phoribosyltransferase (Ordway et al., 1997) . That all of fragments of ataxin-1 enter the nucleus by virtue of the these mouse lines develop a neurological phenotype NLS. In the ataxin-1 K772T Purkinje cells, the C-terminal has encouraged the idea that the larger protein context fragments may enter the nucleus by diffusion. The fact is irrelevant for pathogenesis. Yet, our data clearly demthat nuclear aggregates of ataxin-1 in the B05 Purkinje onstrate that amino acids in ataxin-1 several hundred cells stain intensely with both the 11750 and 11NQ antiresidues distant from the polyglutamine tract can have bodies ( Figures 2D and 2E) suggests they are composed a critical impact on the cellular biology of the polyglumainly of full-length ataxin-1. Thus, these results inditamine protein. While studies of how polyglutamines cate that the initial pathogenic event in SCA1 mice inbehave outside the context of an intact disease protein volves the full-length ataxin-1 protein rather than short may provide important information, an exploration of fragments and occurs at some point between or includpathogenicity in a model predicated on the expression ing nuclear translocation of the protein and its deposiof a full-length polyglutamine-disease protein is clearly tion as nuclear aggregates. The inability to detect exessential for a full understanding of the disease process. panded full-length ataxin-1 on Western blots of extracts from B05 cerebella using either 11NQ or 11750 indicates that these aggregates are insoluble. Finally, the inability Aggregates Is Not Required for the K772T were generated using the same PCR technique to change the
Initiation of SCA1 Pathogenesis
AAG codon to ACG (two overlapping primers of opposite orientation,
The finding of neuronal nuclear aggregates of expanded each containing the base change, were used with flanking primers on an ataxin-1 cDNA template to generate two products overlapping polyglutamine proteins in HD and SCA1 transgenic at the relevant codon; these were annealed and used as template comparing fluorescence intensities, collection and processing parameters were kept constant. For comparing distributions or morto generate a large fragment, which was subcloned back into the cDNA). For the CMPK fusion experiments, a fragment encoding the phologies, parameters were optimized for each image. For quantitating fluorescence intensity, sections that had been double-stained start codon, FLAG sequence, and first nine amino acids of ataxin-1 was subcloned into the 5Ј polylinker of p3PK (Frangioni and Neel, for ataxin (11750, Cy3) and calbindin (CL-300, Cy5) were scanned through 20 m at 2 m increments with 8-bit pixel depth. The 1993). A PCR product encoding amino acids 760-816 of ataxin-1 and tailed with BglII was inserted into the BglII site resulting in scanned area included approximately 10 complete Purkinje cells. Using the Metamorph software package, the ataxin-1 planes were p3PK-FLAG-C', and the coding region was then transferred to pCDNA1, which expressed the NLS region of ataxin-1 fused to additively projected to yield a 16-bit image, while the calbindin planes were projected using maximum value and binarized into a CMPK. Insertion of the corresponding PCR product from K772T template yielded p3PK-FLAG-K772T. In-frame deletion of amino mask. The mask was applied to the 16-bit ataxin image to eliminate extracellular staining. Intensity within the cells was summed and acids within the self-association region was accomplished by digesting ataxin-1 cDNA with NcoI, blunting with mung bean nuclease, normalized against endogenous hippocampal ataxin-1 staining in the same section as an internal control. (Burright et al., 1995) . Both transgene constructs were sequenced from paraffin-embedded brains. For calbindin staining with CL-300, prior to microinjection. no unmasking procedure was used. For ubiquitin staining with Ubi-1, sections were boiled three times for 3-4 min in 0.01 M urea subsequent to rehydration. Staining was carried out using the ABCElite COS Cell Transfections and Immunofluorescence kit (Vector); sections were blocked for 20 min in normal serum, As described (Skinner et al., 1997) , 80% confluent cells were incubated for 1 hr at room temperature (CL-300, 1:1000) or overnight transfected with 5 g of plasmid DNA using the DEAE-dextran at 4ЊC (Ubi-1, 1:3000), washed briefly, and incubated for 1 hr at room method. Cells were transferred to coverslips, fixed, and stained as temperature with biotinylated anti-mouseantibodies. These were described (Quinlan et al., 1984) , with either M5 (anti-FLAG, 1:100, washed briefly, incubated with ABC reagent, washed, exposed for Kodak) or 11750 (anti-ataxin-1, 1:200). Nuclear matrix preparations several minutes to DAB substrate, washed, counterstained, dehywere performed as described (Bisotto et al., 1995) . Images were drated, cleared, and mounted. collected using a confocal microscope (Biorad).
Electron Microscopy Generation and Maintenance of Transgenic Mouse Lines
One ataxin-1[77]⌬3 and one nontransgenic control mouse at 12 Transgenes were linearized by digestion with SalI, gel-purified, and weeks of age, perfused with 4% paraformaldehyde and 0.1% glutardialyzed against injection buffer. A 2 mg/ml solution was injected aldehyde in 0.1 M phosphate buffer (PB), were used for preembedinto FVB embryos, which were implanted into pseudopregnant FVB ding immunogold electron microscopy. The brains were subsefemales. Offspring were screened for presence of the transgene by quently removed and immersed in the same fixative for 2 hr and Southern blot or PCR of tail DNA, as described (Burright et al., 1995) . rinsed in 0.1 M PB. Each cerebellum was sectioned at 50 m using Mice were housed in a conventional facility. a vibratome. The sections were rinsed with phosphate buffered saline (PBS), preblocked in with 4% normal goat serum (NGS) in RNA and Protein Analysis PBS containing 0.05% Triton X-100 for 30 min, and incubated in For Northern blot analysis, RNA was isolated from whole cerebella the 11750 antibody at 1:500 containing 2% NGS for 48 hr at 4ЊC. by the acid guanidinium thiocyanate-phenol/chloroform method Sections were rinsed in PBS and incubated overnight in Fab frag- (Chomczynski and Sacchi, 1987) , electrophoresed in the presence ments of goat anti-rabbit secondary antibodies (1:50) conjugated of glyoxal, blotted, and probed with radiolabeled ataxin-1 cDNA, as to 1.4 nm gold particles (Nanoprobes Inc., Stony Brook, NY) in PBS described (Burright et al., 1995) . For Western blot analysis, whole containing 2% NGS. Sections were rinsed in PBS and fixed in 2% cerebella were homogenized in lysis buffer (10% glycerol, 5% merglutaraldehyde in 0.1M PB for 1 hr. After rinsing in several changes captoethanol, 2.3% SDS, 0.06 M Tris [pH 6.8]). A portion of the of PB, the gold was silver-intensified as previously described (Yi crude lysate was heated with loading buffer and electrophoresed, and Hersch, 1997). Sections were postfixed for 10 min in 0.5% blotted, and probed with 11750 (1:2000) , 11NQ (1:2500), 1F8
OsO 4 in PB, dehydrated in ascending concentrations of ethanol and (1:10,000), Ubi 1 (1:3000), or preimmune serum (1:1000), all with propylene oxide, and embedded in Eponate 12 (Ted Pella, Redding, 0.1% Tween-20. After incubating with anti-rabbit or -mouse HRP CA). Semithin sections were stained with toluidine blue for examinaconjugate, bands were visualized by chemiluminescence (NEN Rention by light microscopy. Ultrathin sections were cut using a Leica naisance kit).
Ultracut S ultramicrotome and collected on uncoated mesh grids. Grids were stained with uranyl acetate and lead citrate and examined using an Hitachi H-7500 electron microscope. Since the immuAssessment of Motor Ability nogold procedure degrades ultrastructural morphology, sections Motor ability was assessed using an accelerating Rotarod apparafrom each animal that were not subjected to the immunogold procetus, as described . Mice were given four trials dure were also examined. In addition, background immunogold laper day for 4 consecutive days, with 10 min rests between trials.
beling was assessed by examining sections processed as above Each trial lasted until the mouse fell from the rod or for a maximum but not exposed to the primary antibody. of 10 min. During a trial, the rod accelerated from 4 to 40 rpm over 5 min and then remained at 40 rpm for the remainder of the trial. Data were analyzed using the SuperANOVA software package (Abacus).
